Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
ThinkAdvisor

Life Health > Health Insurance > Life Insurance Strategies

Employer health care spending tops 4.3% CAGR

X
Your article was successfully shared with the contacts you provided.

Between 2006 and 2011, employer healthcare spending experienced a compounded annual growth rate of 4.3, rising from $3,739 to $4,625 per member per year, according to new research.

These are among the highlights from a Truven Health Analytics report designed to highlight the importance of particular diseases based on their contribution to the growth in employer healthcare spending over a five-year period. Truven Health estimated national spending by employers in 2006 and 2011 for all health care services and for prescription drugs using claims data from MarketScan Research Databases the company developed.

Among all health care services, the report shows, hospital outpatient services grew the fastest, achieving in 2011 a 6.5 percent compounded annual growth rate (CAGR) or $1,344 per member per year (PMPY). All health care services in 2011 grew at the following rates:

Health care category

PMPY

CAGR

Hospital outpatient

$1,344

6.5%

Other setting

$292

4.8%

Inpatient

$1,042

4.3%

Office

$994

3.9%

Pharmacy

$955

2.1%

The report added that the top 20 MEGs — Truven Health “Medical Episode Groupers” that group claims into episodes of care — account for 41 percent of growth in employer health spending from 2006 to 2011.

“The leading MEG is Preventive Health Services, which alone accounted for 9 percent of spending growth,” the report disclosed. “The second-leading contributor to growth was Osteoarthritis, Except Spine — one of six musculoskeletal conditions in the top 20.”

“The third was Multiple Sclerosis, which more than doubled in PMPY spending,” the report added. “That rate was exceeded by Crohn’s Disease, another autoimmune disorder.”

Spending PMPY by major diagnostic category, the report noted, include musculoskeletal (CAGR: 5.6 percent), cancer (4.5 percent), cardiovascular (0.6 percent), gastrointestinal (3.8 percent) and women’s health/reproduction (5.3 percent).

“These results highlight how difficult it will be to manage health care costs while still providing the level of care that U.S. consumers expect,” the report concluded. “[T]he ongoing obesity epidemic is the underlying driver of many of the diseases noted in this report, a problem that will not be solved by improved healthcare delivery alone.”


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.